DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
HoWangYin KY, Loinard C, Bakker W. et al.
HIF-prolyl hydroxylase 2 inhibition enhances the efficiency of mesenchymal stem cell-based therapies for the treatment of critical limb ischemia.
Stem Cells 2014;
32: 231-243.
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.